CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for eganelisib ...

Infiniti is in a tough spot right now and seems to be in a bit of a "throw stuff at the wall and see what sticks" mode. Just last week, the Japanese automaker unveiled the QX80 Sport — a vaguely ...

Infinity Pharmaceuticals, Inc. INFI announced that the FDA has granted Fast Track designation to its lead candidate, eganelisib (IPI-549), in combination with a checkpoint inhibitor and chemotherapy ...

As it turns out, Infiniti is serious about bringing driving enthusiasts back into the fold. The best example we have so far is that the Q50 is on a path of revitalization that will include rear-wheel ...

The powerful capability and confident control of the all-new 2025 INFINITI QX80 is elevated with two provocative concept vehicles. Revealed at The Quail during Monterey Car Week, QX80 Track Spec and ...